Total Funding
75
63
Total FundingSeed raised
Growth Score
-4 pts
Heat Score
-5 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
169666
Canget BioTekpharma is a biotech and biopharma company used to develop novel, cancer-targeting anticancer agents.
- Fengzhi Li: Founder & Chief Scientific Officer
- Alex Adjei: Chief Medical Officer
About the Company
Canget BioTekpharma is a biotech and biopharma company used to develop novel, cancer-targeting anticancer agents. It provides low toxic and cancer-targeting anticancer agents for patients, enabling medical practitioners to improve patient survival time and survival rate through controlling cancer cell drug resistance and tumor relapse. The company
focuses on the development of novel, cancer-targeting anticancer agents that exhibit low toxicity to normal tissue and high efficacy to cancer.
Canget BioTekpharma was established in 2012 and is headquartered in Buffalo, New York.
